| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sell | 2,444 | $232.02 | $567,056.88 | -4.1% | +9.9% | +29.8% | |
| Feb 11, 2022 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 290 | $235.09 | $68,175.14 | -0.1% | +3.0% | +27.2% | |
| Feb 11, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sell | 2,297 | $235.02 | $539,836.69 | -0.9% | +3.0% | +27.2% | |
| Feb 2, 2022 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 1,040 | $250.98 | $261,016.94 | -0.4% | +6.1% | +19.8% | |
| Feb 2, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sale+OE | 4,660 | $251.47 | $1,171,842.12 | -1.0% | +6.1% | +19.8% | |
| Feb 2, 2022 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 2,944 | $250.07 | $736,206.08 | -4.9% | +6.1% | +19.8% | |
| Jan 28, 2022 | McGlynn Margaret G51 | Director | Sale+OE | 5,000 | $241.79 | $1,208,960.27 | -33.3% | +10.5% | +32.3% | |
| Nov 15, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 51 | $187.19 | $9,546.78 | - | +23.7% | +63.4% | |
| Nov 15, 2021 | Arbuckle Stuart A | EVP, COO | Sell | 3 | $187.26 | $561.78 | - | +23.7% | +63.4% | |
| Nov 15, 2021 | Altshuler David48 | EVP, Global Research And CSO | Sell | 34 | $187.22 | $6,365.40 | - | +23.7% | +63.4% |